AcelRx Pharmaceuticals (ACRX) Posts Q4 Loss of 18c/Share

March 3, 2014 4:09 PM EST Send to a Friend
AcelRx Pharmaceuticals (NASDAQ: ACRX) reported Q4 EPS of ($0.18), $0.01 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login